Multigene testing of women negative for BRCA1 and BRCA2 found some of them harbored other harmful genetic mutations, most commonly moderate-risk breast and ovarian cancer genes and Lynch syndrome genes, which increase ovarian cancer risk, according to an article.
http://www.sciencedaily.com/releases/2015/08/150813123035.htm
Multigene panel testing for hereditary breast/ovarian cancer risk assessment
13 agosto 2015
Volver